Table 4.

mRNA vaccines (approved/last part of Phase-III trial) which showing very good safety profile.

Sl no.	mRNA vaccine	Disease	Developer	Status	Remark
1.	BNT162b2	COVID-19	BioNTech and Pfizer	The vaccine is approved, several country have started the vaccination program with this vaccine	This vaccine shows excellent safety profile
2.	mRNA-1273	COVID-19	ModernaTX, Inc.	The vaccine is approved, several country have started the vaccination program with this vaccine	This vaccine shows excellent safety profile
3.	CureVac AG	COVID-19	CureVac N.V.	Registered under Phase-III clinical trial (NCT04860258)	The vaccine showed very good safety profile in Phase-I and Phase-II